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Abstract
Introduction. Resistant hypertension (RHT) is recognized when the blood pressure (BP) is equal to or greater than 
140/90 mmHg, despite changes in lifestyle and using at least 3 antihypertensive drugs, including diuretics at optimal 
doses. Often, patients limit the proper control of BP by voluntary reduction and discontinuation of less tolerated 
drugs, failure to follow healthy lifestyle rules, and taking medications that increase BP. The reason for the lack of 
effects in treatment of hypertension (HT) is also unrecognized secondary HT. 
The aim of the study is to evaluate the occurrence of pseudo-RHT in patients with primary RHT diagnosis.
Material and methods. The study was conducted in 2012–14 among patients hospitalized in the Department of 
Cardiology of The Pope John Paul II Province Hospital in Zamość. 99 patients diagnosed with RHT were examined, 
(59 men) at age 54.5–67.0 on average 60.0 ± 9.8 years. Statistical analysis was performed based on Statistica; Chi2 
and U-Mann-Whitney tests were used.
Results. The final group consisted of 93 people (55 men). In the course of hospitalization, studies were conducted 
for secondary causes of HT. Efficacy of treatment was evaluated, education on healthy lifestyle was conducted and in 
some cases pharmacotherapy was modified. As a result of the diagnostic procedure and increased control of applied 
therapy, 30 patients with true RHT and 63 patients with pseudo-RHT were identified from a group of 93 patients 
with initial RHT. Patients with true RHT (16 men) were proposed renal artery denervation.
Conclusions. A large group of patients with diagnosed RHT are patients with pseudo-RHT. The common cause of 
RHT is the presence of an undetected secondary HT.
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Streszczenie
Wstęp. Nadciśnienie tętnicze oporne (RHT, resistant hypertension) rozpoznaje się, gdy ciśnienie krwi (BP, blood pres-
sure) jest większe lub równe 140/90 mmHg, mimo zmiany stylu życia i stosowania co najmniej 3 leków przeciwnad-
ciśnieniowych, w tym diuretyków, w optymalnych dawkach. Często pacjenci utrudniają osiągnięcie prawidłowej 
kontroli BP przez samowolne zmniejszanie dawki lub odstawianie gorzej tolerowanych leków, nieprzestrzeganie 
zaleceń dotyczących zdrowego stylu życia lub przyjmowanie leków zwiększających BP. Przyczyną nieskuteczności 
leczenia nadciśnienia tętniczego (HT, hypertension) może być również nierozpoznane wtórne HT.
Badanie przeprowadzono w celu oceny częstości występowania rzekomoopornego nadciśnienia tętniczego u chorych 
z pierwotnym rozpoznaniem RHT.
Materiały i metody. Badanie przeprowadzono w latach 2012–2014 wśród chorych hospitalizowanych na Oddziale 
Kardiologii Szpitala Wojewódzkiego im. Jana Pawła II w Zamościu. Zbadano 99 chorych (59 mężczyzn) z rozpozna-
nym RHT w wieku 54,5–67,0 lat (średnia wieku 60,0 ± 9,8 r.).
Analizy statystyczne przeprowadzono, korzystając z  oprogramowania Statistica; wykonano test Chi2 i  test U  Man-
na-Whitneya.
Wyniki. Ostatecznie badana grupa składała się z 93 chorych (55 mężczyzn). W trakcie hospitalizacji u chorych 
wykonano badania pod kątem przyczyn wtórnego HT. Oceniono skuteczność leczenia, przeprowadzono edukację 
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chorych odnośnie do zdrowego stylu życia, a w niektórych przypadkach zmodyfikowano leczenie farmakologiczne.
Po przeprowadzeniu badań diagnostycznych oraz zweryfikowaniu stosowanego leczenia w  grupie 93 chorych 
z pierwotnym rozpoznaniem RHT zidentyfikowano 30 chorych z rzeczywistym RHT i 63 chorych z rzekomoopor-
nym HT. Chorym z rzeczywistym RHT (16 mężczyzn) zaproponowano denerwację tętnic nerkowych.
Wnioski. Dużą grupę chorych z rozpoznaniem RHT stanowią pacjenci z rzekomoopornym HT. Częstą przyczyną 
RHT jest obecność niewykrytego wtórnego HT.
Słowa kluczowe: rzeczywiste nadciśnienie tętnicze oporne, rzekomooporne nadciśnienie tętnicze
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Introduction
Resistant hypertension (RHT) is recognized 
when the blood pressure (BP) is equal to or great-
er than 140/90 mmHg, despite lifestyle modifi-
cations and the use of at least 3 antihypertensive 
drugs, including diuretics at optimal doses [1]. It 
is estimated that the problem of resistance affects 
10–13% of the HT population. It is particularly 
important because of the much higher cardiovas-
cular risk in this group of patients [2]. The reasons 
for lack of response to antihypertensive treatment 
may vary. In some patients it is not possible to 
determine the reasons for the resistance based on 
the available diagnostic methods, while in the re-
maining cases the RHT is diagnosed despite a de-
tectable cause [3]. A common reason is the use of 
an inadequate treatment regimen resulting from 
too low doses of medication and lack of diuretics 
in combination therapy. Patients limit the proper 
control of BP by voluntary reduction and dis-
continuation of less tolerated drugs. Neglecting 
the principles of healthy lifestyle such as weight 
reduction, sodium and alcohol intake and insuffi-
cient physical activity also play an important role. 
It is worth noting that taking certain medications 
(glucocorticosteroids, non-steroidal anti-inflam-
matory drugs, contraceptives) may cause an in-
crease in BP [4]. Ineffective HT treatment is also 
caused by unrecognised secondary HT in renal 
disease, renal artery stenosis, endocrine diseases, 
organic cardiovascular disease, obstructive sleep 
apnea, and others [5].
Very often the high BP values are caused by over-
stress during medical examinations, with normal 
BP values measured at home. This is the so-called 
“white coat” hypertension and it is referred to as pseu-
do-RHT.
It is important to be aware of the possible causes 
of ineffectiveness of HT treatment. The aim of this 
study is to evaluate the occurrence of pseudo-RHT 
in patients with primary RHT diagnosis.
Materials and methods
The study was conducted in 2012–14 among pa-
tients hospitalized in the Department of Cardiolo-
gy of The Pope John Paul II Province Hospital in 
Zamość. The study group initially consisted of 99 
patients (59 men) aged 54.5–67.0 on average 60.0 ± 
9.8 years. All patients were referred from specialized 
cardiac or medical clinics with RHT diagnosis. The 
purpose of hospitalization was to carry out extended 
diagnostic tests for secondary HT, drug intake and 
qualification for possible renal artery irregularity fol-
lowing RHT confirmation. During hospitalization, 
patients had basic laboratory tests such as complete 
blood count, electrolyte levels, renal indexes, urinal-
ysis, fasting glucose levels. In addition, the thyroid 
hormone level, the daily cortisol profile, 24-hour 
urinary metanephrine, the aldosterone-renin index 
were determined. Basic imaging tests were performed 
such as abdominal ultrasound, renal artery flow us-
ing Doppler method and, in some cases, abdominal 
CT scan.
The incidence of true and pseudo-RHT in the 
group primarily diagnosed with RHT was analyzed. 
Patients with true RHT were qualified for renal ar-
tery denervation. Statistical analysis was performed 
based on Statistica; Chi2 and U-Mann-Whitney tests 
were used.
Results
The study group finally consisted of 93 people (55 
men), because 6 patients (6.1% of the respondents) 
did not report to the hospital within the agreed time 
without giving a reason. The course of qualification 
of patients with initial RHT diagnosis for renal ar-
tery denervation is presented in Table I.
At the interview stage, it was determined that 8 
patients (i.e. 8.6% hospitalized) did not receive reg-
ular antihypertensive medication or only took some 
of the prescribed medications. Two of the others 
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table I. Qualification of patients with primary diagnosis of RHT for renal arterial denervation
Stage Number of patients (n) Reason for disqualification Disqualified n, (%)*, (%)** other
n, (%)***
1 99 They did not present for the initial test 6 (6.1) 93 (93.9)
2 93 Irregular outpatient treatment 8 (8.6), (8.6) 85 (85.8)
3 85 Previously recognized secondary HT 2 (2.3), (2.2) 83 (83.8)
4 83 No technical feasibility of the procedure 5 (6.0), (5.4) 78 (78.8)
5 78 Secondary HT diagnosed during hospitalization 24 (30.8), (25.8) 54 (54.5)
6 54 Positive BP control in ambulatory settings 24 (44.4), (25.8) 30 (30.3)
7 30 No consent to surgery 15 (50.0), (16.1) 15 (15.1)****
*percentage of the number of patients at the previous stage
**percentage of the number of hospitalized patients
***number of patients in the subsequent stages of the qualification and percentage of the patients reported
****number and percentage of patients who underwent the procedure
table II. General characteristics of hospitalized patients with suspected RHT. Sociodemographic and disease data
Sociodemographic data total
n = 93 (100,0%)
Patients with true RHT
 n = 30 (32.3%)
Patients with pseudo-RHT
n = 63 (67.7%)
p*
Male gender 55 (59.1) 16 (53.3) 39 (61.9) 0.4318
Age (years) 60.1 (± 10.0) 58.8 (7.1) 60.7 (11.2) 0.1535
Place of residence — city 51 (54.8) 17 (56.7) 34 (54.0) 0.8069
Duration of HT (years) 11.9 (± 6.0) 12.0 (± 5.5) 11.8 (± 6.3) 0.9570
Number of antihypertensive drugs 4.6 (± 0.9) 5.1 (± 0.8) 4.4 (± 0.9) 0.0012
BMI [kg/m2] 31.4 (± 4.6) 32,6 (± 4,6) 30.8 (± 4.6) 0.0453
Diabetes 32 (34.4) 11 (36,7) 21 (33.3) 0.7518
Past stroke 13 (44.0) 5 (16,7) 8 (12.7) 0.6059
Coronary disease 22 (23.7) 7 (23,3) 15 (23.8) 0.9597
Data is presented as n-number of patients (percentage) or mean value (± SD) 
*p for the Chi² test or the Mann-Whitney U test
reported had previously identified secondary HT 
(renal artery stenosis and polycystic kidney disease).
In the course of hospitalization, studies were con-
ducted for secondary causes of HT, efficacy of treat-
ment was assessed, education on healthy lifestyle 
was conducted and in some cases pharmacotherapy 
was modified. After receiving the results, 24 patients 
(25.8% hospitalized) with suspected secondary HT 
due to reasons such as renal artery stenosis (n = 11), 
primary hyperaldosteronism (n = 7), pheochromo-
cytoma (n = 2), hypercortisolemia (n = 2), hyper-
thyroidism (n = 1) and hyperparathyroidism (n = 1) 
were recognised. Some of these patients required 
further diagnostics and specialized treatment. Af-
ter about a  month of hospitalization, patients had 
a  Cardiology Clinic visit combined with Ambula-
tory Blood Pressure Monitoring (ABPM). During 
this visit, another 24 patients (25.8% hospitalized) 
showed satisfactory BP control confirmed by ABPM.
The reason for acquiring the target BP values 
could have been a lifestyle change, a previous mod-
ification of the treatment, and/or a regular intake of 
prescribed medications. From the group of 93 pa-
tients with initial RHT a total of 30 patients (32.3%) 
with true RHT and a  group of 63 (67.5%) with 
pseudo-RHT were identified as a  result of a  diag-
nostic procedure and an increase in the control of 
applied therapy. Patients with true RHT (16 males) 
were proposed for renal artery denervation; half of 
the respondents agreed. 
Sociodemographic data and morbidity in patients 
with true and pseudo-RHT are presented in Table 
II. The groups did not differ in terms of gender, age, 
place of residence, duration of HT and incidence of 
diabetes, stroke and coronary heart disease. Patients 
with true RHT took more medications (5.1 vs. 4.4; p 
= 0.0012). Statistically significant higher body mass 
index (BMI) occurred in patients in this group (32.6 
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table III. General characteristics of hospitalized patients with suspected RHT. Laboratory tests
laboratory tests total
n = 93 (100,0%)
Patients with true RHT
n = 30 (32.3%)
Patients with pseudo-RHT
n = 63 (67.7%)
P*
Hgb [g/dL] 13.8 (± 1.4) 13.9 (± 1.3) 13.7 (± 1.4) 0.6247
RBC [mln/uL] 4.6 (± 0.5) 4.6 (± 0.5) 4.5 (± 0.5) 0.4301
WBC [K/uL] 7.4 (± 1.9) 7.6 (± 1.8) 7.3 (± 1.9) 0.2927
PLT [K/uL]  204.7 (± 47.8) 198.5 (± 38.3) 207.7 (± 51.7) 0.6721
CREAT [mg/dL] 1.0 (± 0.3) 1.0 (± 0.3) 1.0 (± 0.3) 0.2349
K+ [mmol/L] 4.2 (± 0.5) 4.3 (± 0.4) 4.2 (± 0.5) 0.4619
NA+ [mmol/L] 140.4 (± 2.5) 139.7 (± 2.8) 140.8 (± 2.3) 0.0637
Uric acid [mg/dL] 6.1 (± 1.4) 6.0 (± 1.6) 6.2 (± 1.3) 0.6631
Urea [mg/dL] 42.0 (± 12.7) 37.7 (± 11.1) 44.0 (± 13.0) 0.0235
Proteinuria (+) 14 (15.1) 7 (23.3) 7 (11.1) 0.1234
Data is presented as n-number of patients (percentage) or mean value (± SD) 
*p for the Chi² test or the Mann-Whitney U test
vs. 30.8; p = 0.0453). The results of laboratory tests 
are presented in Table III. There was a  statistically 
significant lower level of urea in patients with true 
RHT and a statistically significant low sodium level 
in this group.
discussion
The causes of resistance to HT treatment are very 
different. Attention should be paid to the diagnostic 
insight as up to 24 cases (25.8% of patients) in our 
study were diagnosed with secondary HT. The most 
common cause was renal artery stenosis in 11.8% of 
patients and another was primary hyperaldostero-
nism in 7.5% of patients. The results obtained are 
consistent with literature data, where renal artery 
stenosis is also listed as one of the major causes of 
secondary HT, amongst renal parenchymal disease 
and primary hyperaldosteronism [6]. It is noted that 
the proportion of secondary HT was more frequent 
in the study group compared to earlier publications, 
where 5% of the subjects had secondary HT in the 
RHT group [7]. This difference is due to the limited 
possibility of conducting diagnostic tests in ambula-
tory conditions in patients with previous diagnosis of 
secondary HT, hence the diagnosis was established 
only during hospitalization.
The key role in treatment of HT is the compli-
ance of the patient with the doctor’s instructions 
and adherence to their medical advice. It has been 
recognized since 2003 in the World Health Report 
as an important factor responsible for the outcome 
of HT treatment and includes patient’s compliance 
with recommendations about lifestyle and regular 
medication intake. Another issue is the improper 
treatment that results from a physician’s attitude and 
failure to achieve therapeutic goals due to the lack of 
dose modifications and not adjusting the amount of 
medications. This is the so-called therapeutic inertia. 
Its causes should be sought in the lack of knowledge 
of target BP values, in the fear of too low BP values 
and the belief that the patient will not accept more 
medication [8, 9].
Our research shows that the common cause of 
the lack of proper BP control is the non-compliance 
with the recommended regimen. At the time of ad-
mission to the hospital, it was found that 8 patients 
(8.6%) did not take the recommended medicines. 
Another 24 patients (25.8%) after hospital stay and 
slight modification of treatment received a normal 
BP during a follow-up visit and in ABPM measure-
ments. In the study cited, 58% of patients used an 
inadequate treatment regimen with too low doses of 
diuretics and 16% of patients did not comply with 
the medical advice [7].
In our analysis, true RHT was present in 30% 
of patients with primary RHT diagnosis. Amongst 
this group, patients were found to have significantly 
higher body mass and BMI which demonstrates their 
negligence towards lifestyle modifications, including 
weight reduction. Patients with RHT received sig-
nificantly greater antihypertensive drugs dose; yet, 
they failed to maintain proper BP control.
In evaluating patients with RHT in many previ-
ous studies, it appeared that important predictors 
of BP control failure were age greater than 75 years, 
left ventricular hypertrophy and obesity with a BMI 
above 30 kg/m2 [10]. Patients with RHT were char-
acterized by a higher incidence of organ damage [11]. 
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In our study group of patients with RHT, proteinuria 
also appeared more frequently as an indication of 
renal failure. There was no increased incidence of 
diabetes in patients. Also, RHT occurrence was not 
found to be more common in the elderly.
The study showed that we often encounter pseu-
do-HT resistance. Employing appropriate treatment 
regimens with proper antihypertensive doses and 
patient adherence to treatment recommendations 
and lifestyle modifications significantly reduce the 
number of RHT patients. It is necessary to pay close 
attention to the cooperation between the doctor, the 
district nurse and the patient in order to achieve bet-
ter HT treatment results. Another important prob-
lem is still a large number of unrecognized secondary 
HT forms that can be effectively treated.
Conclusions
1. A relatively large group of patients with recognized 
RHT does not meet the diagnostic criteria and 
these are patients with pseudo-RHT.
2. The common cause of RHT is the presence of an 
undetected secondary HT, diagnostic caution in 
treating patients with RHT should be maintained.
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